CLDI stock price edged higher in early trading, supported by positive sentiment in small-cap tech stocks. Current RSI is at 61, not yet overbought, signaling room for upside if market breadth remains healthy. This is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.' Calidi Biotherapeuticsâ overall stock score reflects significant financial and technical challenges, typical of a developing biotech company. While corporate events bring positive leadership changes and strategic advancements, the companyâs lack of revenue, high leverage, and bearish technical indicators weigh heavily on its score. CLDI stock price edged upward to $2.86 today, extending its weekly gain to 3.4%. Sustained volume indicates that institutional interest may be building in this micro-cap space.
